Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chromadex Corp CDXC

Technology Scientific & Technical Instruments
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished... see more

Recent & Breaking News (NDAQ:CDXC)

ChromaDex Announces Commencement of an Obesity-Related Clinical Study of NIAGEN® in Collaboration With the University of Copenhagen and Aarhus University

GlobeNewswire February 22, 2016

ChromaDex Named to 2016 OTCQX Best 50

Press Releases February 17, 2016

What's Directing Investors Movement -- Consensus Reports on Hemp, Penn Virginia, Chromadex, and Newcrest Mining

Accesswire February 2, 2016

ChromaDex Announces Retail Commercialization Deal With BPI Sports

GlobeNewswire January 27, 2016

NIAGEN® Launches at GNC Stores Nationwide

PR Newswire January 21, 2016

The Road Ahead - Analyst Notes on Saleen Automotive, Axiom Oil and Gas, Agrieuro and Chromadex

Accesswire January 15, 2016

A Letter From the ChromaDex Chief Executive Officer

GlobeNewswire January 6, 2016

ChromaDex Lead Ingredient NIAGEN® Nicotinamide Riboside Achieves GRAS Status

GlobeNewswire January 4, 2016

ChromaDex and American Laboratories Collaborate to Provide Identity Test for Glandular Related Ingredients

GlobeNewswire December 17, 2015

ChromaDex to Present at 27th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 24, 2015

Jarrow Formulas Plans US Retail Launch of a Nicotinamide Riboside Product Featuring ChromaDex's NIAGEN®

GlobeNewswire November 23, 2015

NIH and ChromaDex Announce Material Cooperative Research and Development Agreement to Study the Effects of ChromaDex's NIAGEN® Nicotinamide Riboside on Cockayne Syndrome and Ataxia Telangiectasia

GlobeNewswire November 18, 2015

ChromaDex Lead Ingredient NIAGEN® Nicotinamide Riboside Receives New Dietary Ingredient (NDI) Status From the FDA

GlobeNewswire November 16, 2015

ChromaDex Reports 6th Consecutive Quarter of Record Revenue as Q3 Ingredients Sales Climb 104%

GlobeNewswire November 12, 2015

ChromaDex Enters Into an Exclusive Joint Development Agreement with The Procter & Gamble Company

GlobeNewswire November 5, 2015

ChromaDex Announces $2,000,000 Registered Direct Offering

GlobeNewswire November 5, 2015

ChromaDex to Report Third Quarter 2015 Financial Results on Thursday, November 12, 2015

GlobeNewswire November 3, 2015

Factors Moving Markets - Imageware Systems, NanoTech Entertainment, Pleasant Kids and Chromadex

Accesswire November 2, 2015

ChromaDex Corp. Presentation Now Available for On-Demand Viewing

Canada NewsWire October 7, 2015

OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1

PR Newswire September 28, 2015